Top advances of the year: Cervical cancer

Article Obstetrics & Gynecology

Risk factors for financial toxicity in patients with gynecologic cancer

Emeline M. Aviki et al.

Summary: The study aimed to determine the prevalence and risk factors of financial toxicity in patients with gynecologic cancer. The results showed that financial toxicity is a growing concern for these patients, and factors such as age, marital status, race and ethnicity, insurance type, imaging studies, and outpatient physician visits are significantly associated with financial toxicity.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2022)

添加到收藏夹

Article Oncology

EMPOWER CERVICAL-1: Effects of cemiplimab versus chemotherapy on patient-reported quality of life, functioning and symptoms among women with recurrent cervical cancer

Ana Oaknin et al.

Summary: Cemiplimab showed significant improvements in global health status/quality of life and physical functioning compared to chemotherapy in patients with recurrent cervical cancer. The benefits were particularly pronounced in patients with squamous cell carcinoma. The favorable effects of cemiplimab were observed early in the treatment and were clinically meaningful in terms of role functioning, appetite loss, and pain.

EUROPEAN JOURNAL OF CANCER (2022)

添加到收藏夹

Article Oncology

Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017

Ashish A. Deshmukh et al.

Summary: The incidence of HPV-associated anal and oropharyngeal cancer has increased among US women, while trends for noncervical HPV-associated cancers relative to cervical cancer are unclear. Anal cancer incidence has surpassed cervical cancer among White women, and the burden of noncervical cancers exceeded cervical cancer in 2013. Effective screening strategies for noncervical cancers and improved cervical cancer prevention are needed to address HPV-associated cancers among women.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2021)

添加到收藏夹

Meeting Abstract Oncology